AI assistant
Avery Dennison Corp — Director's Dealing 2022
Mar 4, 2022
30491_dirs_2022-03-03_6b10fc7e-a749-491b-baf3-026ba565a5fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Avery Dennison Corp (AVY)
CIK: 0000008818
Period of Report: 2022-03-01
Reporting Person: STANDER DEON (President & COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-01 | Common Stock | M | 2008 | $170.60 | Acquired | 33181 | Direct |
| 2022-03-01 | Common Stock | F | 600 | $170.60 | Disposed | 32581 | Direct |
| 2022-03-01 | Common Stock | M | 1879 | $170.60 | Acquired | 34460 | Direct |
| 2022-03-01 | Common Stock | F | 589 | $170.60 | Disposed | 33871 | Direct |
| 2022-03-01 | Common Stock | M | 1918 | $170.60 | Acquired | 35789 | Direct |
| 2022-03-01 | Common Stock | F | 851 | $170.60 | Disposed | 34938 | Direct |
| 2022-03-01 | Common Stock | M | 790 | $170.60 | Acquired | 35728 | Direct |
| 2022-03-01 | Common Stock | F | 351 | $170.60 | Disposed | 35377 | Direct |
| 2022-03-01 | Common Stock | M | 5055 | $170.60 | Acquired | 40432 | Direct |
| 2022-03-01 | Common Stock | F | 2253 | $170.60 | Disposed | 38179 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | 2018 MSU Award | $0 | M | 2008 | Disposed | 2022-03-01 | Common Stock (2008) | Direct |
| 2022-03-01 | 2019 MSU Award | $0 | M | 1879 | Disposed | 2023-03-01 | Common Stock (1879) | Direct |
| 2022-03-01 | 2020 MSU Award | $0 | M | 1918 | Disposed | 2024-03-01 | Common Stock (1918) | Direct |
| 2022-03-01 | 2021 MSU Award | $0 | M | 790 | Disposed | 2025-03-01 | Common Stock (790) | Direct |
| 2022-03-01 | 2019 PU Award | $0 | M | 5055 | Disposed | 2022-03-01 | Common Stock (5055) | Direct |
| 2022-03-01 | 2022 MSU Award | $0 | A | 7405 | Acquired | 2026-03-01 | Common Stock (7405) | Direct |
| 2022-03-01 | 2022 PU Award | $0 | A | 5943 | Acquired | 2025-03-01 | Common Stock (5943) | Direct |
| 2022-03-01 | 2022 Special RSU Award | $0 | A | 8793 | Acquired | 2025-03-01 | Common Stock (8793) | Direct |
Footnotes
F1: Shares reflect the vesting of the fourth tranche of market-leveraged stock units granted in February 2018 at 200% of target based on our absolute total stockholder return in excess of 10% during the 2018-2021 performance period, plus dividend equivalents accrued during the period.
F2: Shares reflect the vesting of the third tranche of market-leveraged stock units granted in February 2019 at 200% of target based on our absolute total stockholder return in excess of 10% during the 2019-2021 performance period, plus dividend equivalents accrued during the period.
F3: Shares reflect the vesting of the second tranche of market-leveraged stock units granted in February 2020 at 183% of target based on our absolute total stockholder return in excess of 10% during the 2020-2021 performance period, plus dividend equivalents accrued during the period.
F4: Shares reflect the vesting of the first tranche of market-leveraged stock units granted in February 2021 at 135% of target based on our absolute total stockholder return in excess of 10% during the 2021 performance period, plus dividend equivalents accrued during the period.
F5: Shares reflect the vesting of performance units granted in February 2019 at 115% of target, 75% based on RBIS's cumulative economic value added and 25% on our relative stockholder return.
F6: Market-leveraged stock units vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return, plus dividend equivalents accrued during the vesting period. Each market-leveraged stock unit represents a contingent right to receive one share of our common stock, plus dividend equivalents.
F7: Performance units vest, if at all, at the end of fiscal year 2024, provided the designated performance objectives are met as determined by the Compensation Committee in February 2025. Each performance unit represents a contingent right to receive one share of our common stock.
F8: Restricted stock units vest in full on the third anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of our common stock.